Melanocyte transformation associated with substrate adhesion impediment.
about
Neoplasia: Where We Have Been and Where We Are GoingNeoplasia: the second decade.Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanomaTimp1 Promotes Cell Survival by Activating the PDK1 Signaling Pathway in Melanoma.Differential gene expression and clonal selection during cellular transformation induced by adhesion deprivation.Metabolism under hypoxia in Tm1 murine melanoma cells is affected by the presence of galectin-3, a metabolomics approachMining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasisActivation of the kinin B1 receptor attenuates melanoma tumor growth and metastasis.Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies.Acquisition of anoikis resistance up-regulates syndecan-4 expression in endothelial cells.Biomarkers as key contributors in treating malignant melanoma metastases.Apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor.Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells.Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformationHeparan sulfate proteoglycans: structure, protein interactions and cell signaling.NMR metabolic fingerprints of murine melanocyte and melanoma cell lines: application to biomarker discovery.Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages.Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy.Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylationThe Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation.B-1 cell: the precursor of a novel mononuclear phagocyte with immuno-regulatory properties.HaCaT anchorage blockade leads to oxidative stress, DNA damage and DNA methylation changes.Neoplasia: An Anniversary of Progress.SIRT1 regulates Mxd1 during malignant melanoma progression.Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
P2860
Q28395095-8A3D2E8B-7635-4990-9BCC-4A84D1046E36Q30484000-F69421A4-BAF3-4F8D-86B1-ECE591C25928Q33588271-1A2364AC-4792-470C-B723-262DBE717A24Q33607957-8321E6E5-8626-4A39-BE28-97A2E617A0A1Q33760006-E7B8B4F6-4E81-4113-9439-2683D7F5A4B4Q34168148-77DC9759-C585-40A4-8704-6FAAE04029CFQ34416127-063DFE11-463E-498A-8469-9DFF2C5DE826Q34731651-89C8A73E-252F-4444-921D-6F1A5828131DQ35072584-6BD7E96B-1199-49F3-9355-7EA0FC56801FQ35161541-66C9E8CB-2B23-488E-9868-225A1B96D7E3Q35535743-629446C8-01DE-421B-B36D-F1EE7D4F8E30Q35550888-83801CB3-7052-48D1-B0CA-2EC2B4C96A71Q35942528-30B9A46E-5BAA-41BD-8831-A2B99D25F9C7Q35985447-2E733347-F998-4607-B856-37EB4BFA28DBQ36710853-C354BD61-2787-47EC-8C34-1CE136B9DE86Q37429861-62B26829-3BA4-401D-8A59-11170854E40BQ37590177-8B455813-A5AE-4ECA-89DD-6A2BD87A8836Q38716429-D7482502-934F-4D94-9F5D-BDEDAE23678EQ38758852-DD1F4914-0A92-483D-BC37-D99D015DF97BQ38793339-BEAAF2D0-7A26-4C7E-A42F-84C10B5213CDQ39177033-B111A340-6CA7-4D28-9236-C528345D598FQ40262798-6A207906-9C7F-43B5-ACAF-C81FF1C9AE19Q41939929-E1F18ABA-BF85-4D3D-BEE2-9EE5648F6412Q43547266-B6D4F329-5184-4F34-B43C-445344227D18Q46722663-CE723642-2C05-45DE-B6E2-76D863AFAA48Q46932476-D148FD40-3322-46C8-B860-0174659D70E1Q49569717-EF5862FD-E6B7-424F-A496-B0D4014039F7Q53734974-CC5E2623-2CE9-40EF-8E87-3F20F0947BBD
P2860
Melanocyte transformation associated with substrate adhesion impediment.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Melanocyte transformation associated with substrate adhesion impediment.
@ast
Melanocyte transformation associated with substrate adhesion impediment.
@en
type
label
Melanocyte transformation associated with substrate adhesion impediment.
@ast
Melanocyte transformation associated with substrate adhesion impediment.
@en
prefLabel
Melanocyte transformation associated with substrate adhesion impediment.
@ast
Melanocyte transformation associated with substrate adhesion impediment.
@en
P2093
P2860
P50
P356
P1433
P1476
Melanocyte transformation associated with substrate adhesion impediment
@en
P2093
Fernanda Molognoni
Izabel A Neves
Lúcia O Sampaio
Maria A Pinhal
Roger Chammas
Sueli M Oba-Shinjo
Tatiana I Ricca
P2860
P304
P356
10.1593/NEO.05781
P577
2006-03-01T00:00:00Z